Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -1.92K | 85.69%-47.09K | 54.00%-449.13K | 60.68%-1.26M | 105.67%43.41K | 0 | 61.80%-329.07K | -11.90%-976.39K | 8.43%-3.21M | -9.82%-765.63K |
| Net income from continuing operations | 7,135,225.00%285.41K | 119.29%141.95K | 85.25%-116.53K | 79.01%-726.64K | 150.85%799.48K | 100.00%4 | 0.61%-735.9K | -266.98%-790.22K | 16.96%-3.46M | 13.92%-1.57M |
| Operating gains losses | ---494.69K | -295.63%-353.41K | 7.20%-271.34K | -167.83%-1.33M | -327.54%-1.22M | --0 | 170.78%180.65K | 45.44%-292.4K | -427.60%-496.4K | 571.37%535.19K |
| Depreciation and amortization | --0 | --0 | --0 | -59.35%12.08K | --0 | --0 | -36.52%4.83K | -4.77%7.25K | -65.22%29.73K | -9.56%6.89K |
| Unrealized gains and losses of investment securities | ---- | ---- | ---- | --0 | --0 | --0 | ---- | ---- | --5.38K | --5.38K |
| Remuneration paid in stock | --6.82K | -81.27%4.28K | -62.70%9.9K | -31.98%56.96K | -87.31%7.54K | --0 | --22.87K | --26.55K | -78.37%83.73K | -84.67%59.36K |
| Other non cashItems | --5.47K | --5.49K | --1.39K | --115.84K | ---- | ---- | ---- | ---- | ---- | ---- |
| Change In working capital | 4,876,775.00%195.07K | -22.11%154.6K | -200.16%-72.55K | -3.33%609.26K | 69.37%338.35K | -100.00%-4 | 56.73%198.48K | 156.18%72.43K | 1,456.65%630.22K | -76.44%199.77K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | ---1.92K | 85.69%-47.09K | 54.00%-449.13K | 60.68%-1.26M | 105.67%43.41K | --0 | 60.69%-329.07K | -11.90%-976.39K | 8.43%-3.21M | -9.82%-765.63K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 0 | 0 | 0 | 0 | 0 | 2M | 0 | |||
| Dividends received (cash flow from investment activities) | ---- | ---- | ---- | --0 | --0 | --0 | --0 | --0 | --2M | --0 |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | ---- | ---- | ---- | --0 | --0 | --0 | --0 | --0 | --2M | --0 |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 0 | 771.14%40K | 6,116.84%457.4K | 55.62%-13.56K | 0 | 0 | 21.30%-5.96K | -2.18%-7.6K | 45.01%-30.56K | -2.15%-7.84K |
| Net issuance payments of debt | --0 | 771.14%40K | 4,572.51%340K | 55.62%-13.56K | --0 | --0 | 21.30%-5.96K | -2.18%-7.6K | 66.63%-30.56K | -2.15%-7.84K |
| Net common stock issuance | --0 | --0 | --117.4K | ---- | ---- | --0 | --0 | --0 | ---- | ---- |
| Proceeds from stock option exercised by employees | ---- | ---- | ---- | ---- | ---- | --0 | --0 | --0 | --0 | --0 |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | --0 | 771.14%40K | 6,116.84%457.4K | 55.62%-13.56K | --0 | --0 | 21.30%-5.96K | -2.18%-7.6K | 45.01%-30.56K | -2.15%-7.84K |
| Net cash flow | ||||||||||
| Beginning cash position | 113.17%5.17K | -95.86%12.26K | -99.69%3.99K | -49.19%1.28M | -101.91%-39.24K | -101.40%-39.24K | -81.93%296.42K | -49.19%1.28M | -58.54%2.52M | -36.33%2.05M |
| Current changes in cash | ---1.92K | 97.88%-7.09K | 100.84%8.27K | -2.89%-1.28M | 105.61%43.41K | --0 | -128.98%-335.03K | -11.82%-983.99K | 65.18%-1.24M | -9.74%-773.47K |
| Effect of exchange rate changes | --0 | --0 | --0 | --0 | 83.96%-187 | --0 | 31.17%-627 | -54.65%814 | -81.75%772 | 61.04%-1.17K |
| End cash Position | 108.28%3.25K | 113.17%5.17K | -95.86%12.26K | -99.69%3.99K | -99.69%3.99K | -101.91%-39.24K | -101.40%-39.24K | -81.93%296.42K | -49.19%1.28M | -49.19%1.28M |
| Free cash from | ---1.92K | 85.69%-47.09K | 54.00%-449.13K | 60.68%-1.26M | 105.67%43.41K | --0 | 60.69%-329.07K | -11.90%-976.39K | 8.43%-3.21M | -9.82%-765.63K |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.